Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride

Movement Disorders : Official Journal of the Movement Disorder Society
A AntoniniK L Leenders

Abstract

We used [11C]raclopride (RACLO) and positron emission tomography (PET) to study longitudinally striatal dopamine D2 receptor binding in nine patients with Parkinson's disease (PD) at an early drug-naive stage and 3-5 years later, when motor fluctuations had appeared in seven of them. Patients were treated with a combination of levodopa and dopamine agonists. Data were compared with 10 healthy controls in the same age range. Initially, patients with PD showed a significant increase of RACLO uptake in the putamen compared with controls (p < 0.04). The caudate nucleus revealed values in the normal range. After 3-5 years, RACLO binding was significantly reduced in the putamen (p < 0.03) and caudate nucleus (p < 0.03) compared with baseline. Values were now in the control range in the putamen and reduced in the caudate nucleus (p < 0.05). The clinical score at "off" had significantly worsened (p < 0.0005) compared with the first PET scan. The nine PD patients reported here had already been investigated 3-4 months after therapy began and that time did not show a reduction of the initially increased RACLO binding capacity (data published previously). These results indicate long-term downregulation of striatal dopamine D2 receptor bind...Continue Reading

References

Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·U K RinneU Ruotsalainen
Jan 1, 1985·Journal of Neural Transmission·M Guttman, P Seeman
Sep 1, 1994·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·D EidelbergS Przedborski

❮ Previous
Next ❯

Citations

Dec 10, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·C DentresangleE Brousolle
Mar 29, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Yun J KimAnthony E Lang
Dec 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Craig D McCollPeter A Kempster
Dec 19, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·G BerdingW H Knapp
Apr 16, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·A AntoniniD Eidelberg
Oct 2, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·H L RyooJ N Joyce
May 16, 2006·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Yang MeiXuebing Cao
Nov 2, 2007·Experimental Brain Research·R ChamN I Bohnen
Dec 8, 2004·European Journal of Nuclear Medicine and Molecular Imaging·G M KnudsenL Werdelin
Apr 21, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Maria-João RibeiroAndré Syrota
Oct 21, 2006·European Journal of Nuclear Medicine and Molecular Imaging·C C P VerstappenM W I M Horstink
Dec 12, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Jo Ann V Antenor-DorseyJoel S Perlmutter
Jul 25, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Kenji IshibashiKenji Ishii
Jan 29, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Chrissa SiokaAthanassios P Kyritsis
Jul 2, 2008·Current Neurology and Neuroscience Reports·Shyamal H MehtaKapil D Sethi
Mar 23, 2004·Sleep Medicine·Angelo Antonini, Roberta DeNotaris
Jul 30, 2003·Neurobiology of Aging·Kazunori KawamuraKiichi Ishiwata
May 2, 2001·Parkinsonism & Related Disorders·J N. JoyceT Beach
Apr 13, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Svetlana I CheferAlexey G Mukhin
Oct 8, 1998·The New England Journal of Medicine·A E Lang, A M Lozano
Sep 11, 2012·Brain : a Journal of Neurology·YaJun ZhangCristina M Bäckman
Oct 17, 2002·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Chisako OyanagiHiroshi Shibasaki
Jun 5, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·G K WenningW Poewe
Feb 23, 2002·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Thomas MullerHorst Przuntek
Oct 19, 2011·Parkinson's Disease·Sylvia Navailles, Philippe De Deurwaerdère
Feb 2, 2016·Expert Review of Neurotherapeutics·Musleh A Algarni, A Jon Stoessl
Mar 15, 2014·Journal of Neurology·Flavia NiccoliniMarios Politis
Oct 9, 2007·Parkinsonism & Related Disorders·Peter RiedererHeinz Reichmann
Oct 22, 2011·Lancet Neurology·A Jon StoesslVesna Sossi
Oct 22, 2002·Expert Opinion on Pharmacotherapy·Thomas Müller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.